血管导管相关感染预防与控制指南(2021 版)

2021-08-29 中华人民共和国国家卫生健康委员会 国家卫生健康委办公厅

留置血管内导管是为患者实施诊疗时常用的 医疗操作技术。置管后的患者存在发生血管导管 相关感染的风险。

中文标题:

血管导管相关感染预防与控制指南(2021 版)

发布日期:

2021-08-29

简要介绍:

留置血管内导管是为患者实施诊疗时常用的 医疗操作技术。置管后的患者存在发生血管导管 相关感染的风险。血管导管根据进入血管的不同分为动脉导管和静脉导管,静脉导管根据导管尖 端最终进入血管位置分为中心静脉导管和外周静脉导管。

相关资料下载:
[AttachmentFileName(sort=1, fileName=_血管导管相关感染预防与控制指南(2021版).pdf)] GetToolGuiderByIdResponse(projectId=1, id=f8d841c00216e0ba, title=血管导管相关感染预防与控制指南(2021 版), enTitle=, guiderFrom=国家卫生健康委办公厅, authorId=0, author=, summary=留置血管内导管是为患者实施诊疗时常用的 医疗操作技术。置管后的患者存在发生血管导管 相关感染的风险。, cover=https://img.medsci.cn/2021829/1630248813455_5579292.png, journalId=0, articlesId=null, associationId=1653, associationName=中华人民共和国国家卫生健康委员会, associationIntro=, copyright=0, guiderPublishedTime=Sun Aug 29 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="page" title="Page 1"> <div class="layoutArea"> <div class="column"> <p>留置血管内导管是为患者实施诊疗时常用的 医疗操作技术。置管后的患者存在发生血管导管 相关感染的风险。血管导管根据进入血管的不同分为动脉导管和静脉导管,静脉导管根据导管尖 端最终进入血管位置分为中心静脉导管和外周静脉导管。</p> </div> </div> </div>, tagList=[TagDto(tagId=114217, tagName=血管导管相关感染)], categoryList=[CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=846, guiderKeyword=感染, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5545, appHits=349, showAppHits=0, pcHits=1169, showPcHits=5196, likes=1, shares=35, comments=10, approvalStatus=1, publishedTime=Mon Aug 30 09:48:22 CST 2021, publishedTimeString=2021-08-29, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=FUNNYMAN, createdTime=Sun Aug 29 22:53:47 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Fri Jan 05 23:13:11 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=_血管导管相关感染预防与控制指南(2021版).pdf)])
_血管导管相关感染预防与控制指南(2021版).pdf
下载请点击:
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1201071, encodeId=d77c12010e1b4, content=血液透析很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0af5475963, createdName=ms9000001115066421, createdTime=Wed Mar 09 22:11:33 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195919, encodeId=496e119591992, content=想要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69086515692, createdName=ms2000001633665426, createdTime=Tue Feb 22 00:23:33 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178918, encodeId=7aa411e8918a5, content=想要下载,没有积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201228/94663b62bce44b249b63774ff82e5d13/ea26c9e13943479995cd0bc03ff5393c.jpg, createdBy=5a955122682, createdName=敏敏, createdTime=Thu Dec 30 17:25:55 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076146, encodeId=f8c310e614666, content=想要下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2252481615, createdName=1245cac4m23暂无昵称, createdTime=Thu Dec 02 10:23:18 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061148, encodeId=0d3e1061148ab, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad901494890, createdName=dr-jin, createdTime=Sun Oct 17 00:22:01 CST 2021, time=2021-10-17, status=1, ipAttribution=)]
    2022-03-09 ms9000001115066421

    血液透析很实用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1201071, encodeId=d77c12010e1b4, content=血液透析很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0af5475963, createdName=ms9000001115066421, createdTime=Wed Mar 09 22:11:33 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195919, encodeId=496e119591992, content=想要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69086515692, createdName=ms2000001633665426, createdTime=Tue Feb 22 00:23:33 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178918, encodeId=7aa411e8918a5, content=想要下载,没有积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201228/94663b62bce44b249b63774ff82e5d13/ea26c9e13943479995cd0bc03ff5393c.jpg, createdBy=5a955122682, createdName=敏敏, createdTime=Thu Dec 30 17:25:55 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076146, encodeId=f8c310e614666, content=想要下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2252481615, createdName=1245cac4m23暂无昵称, createdTime=Thu Dec 02 10:23:18 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061148, encodeId=0d3e1061148ab, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad901494890, createdName=dr-jin, createdTime=Sun Oct 17 00:22:01 CST 2021, time=2021-10-17, status=1, ipAttribution=)]
    2022-02-22 ms2000001633665426

    想要积分

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1201071, encodeId=d77c12010e1b4, content=血液透析很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0af5475963, createdName=ms9000001115066421, createdTime=Wed Mar 09 22:11:33 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195919, encodeId=496e119591992, content=想要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69086515692, createdName=ms2000001633665426, createdTime=Tue Feb 22 00:23:33 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178918, encodeId=7aa411e8918a5, content=想要下载,没有积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201228/94663b62bce44b249b63774ff82e5d13/ea26c9e13943479995cd0bc03ff5393c.jpg, createdBy=5a955122682, createdName=敏敏, createdTime=Thu Dec 30 17:25:55 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076146, encodeId=f8c310e614666, content=想要下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2252481615, createdName=1245cac4m23暂无昵称, createdTime=Thu Dec 02 10:23:18 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061148, encodeId=0d3e1061148ab, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad901494890, createdName=dr-jin, createdTime=Sun Oct 17 00:22:01 CST 2021, time=2021-10-17, status=1, ipAttribution=)]
    2021-12-30 敏敏

    想要下载,没有积分

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1201071, encodeId=d77c12010e1b4, content=血液透析很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0af5475963, createdName=ms9000001115066421, createdTime=Wed Mar 09 22:11:33 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195919, encodeId=496e119591992, content=想要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69086515692, createdName=ms2000001633665426, createdTime=Tue Feb 22 00:23:33 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178918, encodeId=7aa411e8918a5, content=想要下载,没有积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201228/94663b62bce44b249b63774ff82e5d13/ea26c9e13943479995cd0bc03ff5393c.jpg, createdBy=5a955122682, createdName=敏敏, createdTime=Thu Dec 30 17:25:55 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076146, encodeId=f8c310e614666, content=想要下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2252481615, createdName=1245cac4m23暂无昵称, createdTime=Thu Dec 02 10:23:18 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061148, encodeId=0d3e1061148ab, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad901494890, createdName=dr-jin, createdTime=Sun Oct 17 00:22:01 CST 2021, time=2021-10-17, status=1, ipAttribution=)]
    2021-12-02 1245cac4m23暂无昵称

    想要下载

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1201071, encodeId=d77c12010e1b4, content=血液透析很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0af5475963, createdName=ms9000001115066421, createdTime=Wed Mar 09 22:11:33 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195919, encodeId=496e119591992, content=想要积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69086515692, createdName=ms2000001633665426, createdTime=Tue Feb 22 00:23:33 CST 2022, time=2022-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178918, encodeId=7aa411e8918a5, content=想要下载,没有积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201228/94663b62bce44b249b63774ff82e5d13/ea26c9e13943479995cd0bc03ff5393c.jpg, createdBy=5a955122682, createdName=敏敏, createdTime=Thu Dec 30 17:25:55 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076146, encodeId=f8c310e614666, content=想要下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2252481615, createdName=1245cac4m23暂无昵称, createdTime=Thu Dec 02 10:23:18 CST 2021, time=2021-12-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061148, encodeId=0d3e1061148ab, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ad901494890, createdName=dr-jin, createdTime=Sun Oct 17 00:22:01 CST 2021, time=2021-10-17, status=1, ipAttribution=)]
    2021-10-17 dr-jin

    0

拓展阅读

2009 ESCMID:艰难梭菌感染 (CDI)治疗指南

欧洲临床微生物与感染性疾病学会(ESCMID,European Society of Clinical Microbiology and Infectious Diseases) · 2009-12-01

2009 皮肤及软组织感染诊断和治疗共识

中国医师协会皮肤科医师分会 · 2009-12-01

2010 OARAC 抗逆转录病毒药物使用指南:美国HIV感染孕妇(孕妇健康和减少围产期HIV传播)

艾滋病研究咨询理事会(OARAC,Office of AIDS Research Advisory Council) · 2010-01-01

2010 IDSA指南:成人与儿童复杂腹腔内感染的诊断与治疗

美国感染病学会(IDSA,Infectious Diseases Society of America) · 2010-01-01

2010 CDC 使用干扰素释放试验检测结核分枝杆菌感染:美国 2010

美国疾病控制与预防中心(CDC,Centers for Disease Control and Prevention) · 2010-01-01

2010UK在学校和其他幼儿设置的感染控制指引(猩红热)

英国健康保护局(HPA,Health Protection Agency) · 2010-01-01